Skip to main content
Journal ArticleOPEN ACCESS

Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program

Open Forum Infectious Diseases (2018) 5(4)
DOI: 10.1093/ofid/ofy048
43Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Hepatitis C virus (HCV) is a significant public health problem that disproportionately afflicts people who inject drugs. We describe outcomes of HCV treatment co-located within a syringe services program (SSP). Fifty-three participants started therapy, and 91% achieved sustained virologic response. SSPs provide an effective venue for HCV treatment.

Author supplied keywords

Cite

CITATION STYLE

APA

Eckhardt, B. J., Scherer, M., Winkelstein, E., Marks, K., & Edlin, B. R. (2018). Hepatitis C treatment outcomes for people who inject drugs treated in an accessible care program located at a syringe service program. Open Forum Infectious Diseases, 5(4). https://doi.org/10.1093/ofid/ofy048

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free